A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

The risk for progression to high-grade dysplasia and esophageal adenocarcinoma was found to be increased in patients with both Barrett’s esophagus and confirmed persistent low-grade dysplasia ...

For each compartment, the number of anti-phosphorylated histone H3-positive nuclei was higher in low-grade dysplasia than in Barrett's esophagus without dysplasia or indefinite for dysplasia (P<0. ...

Detection of low-grade dysplasia on the index endoscopy was associated with an incidence rate for adenocarcinoma of 5.1 cases per 1000 person-years.

Learn about the "pill-on-a-thread" that could replace endoscopies for half of all patients at risk of developing esophageal cancer.

Men tend to develop Barrett’s esophagus twice as often as women. Caucasian men develop this condition more often than men of other races.* Barrett’s Esophagus Dysplasia If Barrett’s esophagus ...

Patients with low-grade dysplasia have around a one in 10 chance of developing esophageal cancer, but this risk doubles to one in five for high-grade dysplasia.

These cells can progress to a condition called dysplasia, which may in turn become cancer. Dysplasia is considered low-grade or high-grade, depending on the degree of cellular change.

Data shows that using TissueCypher results can significantly improve management decisions for Barrett’s esophagus patients with low-grade dysplasia.

The TissueCypher Barrett’s Esophagus test is Castle’s precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with ...

“While the benefit is clear for patients with high-grade dysplasia, we suggest considering endoscopic eradication therapy for patients with low-grade dysplasia after clearly discussing the risks ...

Castle Biosciences’ TissueCypher® test can offer patients with Barrett’s esophagus a clearer picture of their risk of developing esophageal cancer. Esophageal cancer is a killer. It’s the ...